LRMR · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2024-10-30 compared with 2024-08-08 · 2 added, 4 removed, 23 unchanged (21% of the section changed)
2 unchanged sentences
EXHIBIT INDEX
−Removed: Certificate of Amendment of Ninth Amended and Restated Certificate of Incorporation of Larimar Therapeutics, Inc.
−Removed: Sales Agreement, dated as of May 9, 2024, by and between the Company and Guggenheim Securities, LLC (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on May 9, 2024).
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
9 unchanged sentences
LARIMAR THERAPEUTICS, INC.
−Removed: August 8, 2024
+Added: October 30, 2024
/s/ Carole S.
3 unchanged sentences
(Principal Executive Officer)
−Removed: August 8, 2024
+Added: October 30, 2024
/s/ Michael Celano
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.